Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | KOD |
---|---|---|
09:32 ET | 4932 | 2.97 |
09:34 ET | 119 | 2.98 |
09:36 ET | 783 | 2.96 |
09:50 ET | 700 | 2.95 |
09:52 ET | 500 | 2.9793 |
09:54 ET | 225 | 2.95 |
09:57 ET | 700 | 2.965 |
09:59 ET | 100 | 2.965 |
10:01 ET | 100 | 2.965 |
10:03 ET | 100 | 2.965 |
10:08 ET | 1000 | 2.9508 |
10:15 ET | 9000 | 2.96 |
10:17 ET | 1327 | 2.96 |
10:19 ET | 400 | 2.97 |
10:24 ET | 100 | 2.98 |
10:30 ET | 7552 | 2.9901 |
10:48 ET | 100 | 2.98 |
10:51 ET | 100 | 2.98 |
10:55 ET | 119 | 2.97 |
10:57 ET | 500 | 2.97 |
11:02 ET | 510 | 2.96 |
11:04 ET | 260 | 2.9508 |
11:08 ET | 300 | 2.969 |
11:20 ET | 150 | 2.95 |
11:22 ET | 1120 | 2.94 |
11:27 ET | 163 | 2.9499 |
11:29 ET | 1163 | 2.93 |
11:38 ET | 400 | 2.94 |
11:44 ET | 100 | 2.94 |
11:49 ET | 400 | 2.945 |
11:51 ET | 103 | 2.945 |
11:56 ET | 200 | 2.945 |
11:58 ET | 1200 | 2.9416 |
12:00 ET | 101 | 2.945 |
12:03 ET | 790 | 2.93 |
12:12 ET | 200 | 2.925 |
12:25 ET | 684 | 2.9298 |
12:30 ET | 600 | 2.9297 |
12:34 ET | 4414 | 2.94 |
12:36 ET | 578 | 2.94 |
12:39 ET | 1312 | 2.93 |
12:43 ET | 100 | 2.93 |
12:45 ET | 100 | 2.92 |
12:48 ET | 5200 | 2.93 |
12:50 ET | 100 | 2.92 |
12:52 ET | 100 | 2.93 |
12:54 ET | 200 | 2.92 |
12:56 ET | 200 | 2.93 |
12:57 ET | 100 | 2.92 |
12:59 ET | 350 | 2.9325 |
01:01 ET | 6640 | 2.945 |
01:03 ET | 700 | 2.94 |
01:06 ET | 100 | 2.94 |
01:08 ET | 500 | 2.94 |
01:14 ET | 100 | 2.95 |
01:15 ET | 200 | 2.945 |
01:17 ET | 765 | 2.9345 |
01:21 ET | 5000 | 2.94 |
01:24 ET | 226 | 2.94 |
01:26 ET | 200 | 2.94 |
01:28 ET | 135 | 2.9307 |
01:30 ET | 816 | 2.935 |
01:37 ET | 3338 | 2.93 |
01:44 ET | 100 | 2.93 |
01:51 ET | 24349 | 2.9201 |
01:57 ET | 100 | 2.92 |
02:00 ET | 200 | 2.92 |
02:02 ET | 6265 | 2.9 |
02:04 ET | 2169 | 2.88 |
02:08 ET | 3348 | 2.87 |
02:13 ET | 500 | 2.885 |
02:15 ET | 100 | 2.89 |
02:22 ET | 1100 | 2.889 |
02:24 ET | 1300 | 2.9 |
02:26 ET | 700 | 2.9 |
02:27 ET | 100 | 2.9 |
02:29 ET | 100 | 2.895 |
02:31 ET | 100 | 2.895 |
02:33 ET | 1106 | 2.895 |
02:42 ET | 6329 | 2.89 |
02:44 ET | 100 | 2.895 |
02:45 ET | 500 | 2.9 |
02:51 ET | 1396 | 2.91 |
02:56 ET | 994 | 2.915 |
02:58 ET | 200 | 2.92 |
03:02 ET | 500 | 2.9119 |
03:03 ET | 200 | 2.91 |
03:05 ET | 100 | 2.91 |
03:14 ET | 200 | 2.901 |
03:21 ET | 1597 | 2.9 |
03:34 ET | 1879 | 2.91 |
03:36 ET | 1798 | 2.9 |
03:38 ET | 100 | 2.9 |
03:41 ET | 1600 | 2.895 |
03:45 ET | 100 | 2.9 |
03:48 ET | 300 | 2.895 |
03:50 ET | 200 | 2.895 |
03:54 ET | 600 | 2.89 |
03:56 ET | 2913 | 2.89 |
03:57 ET | 1788 | 2.895 |
03:59 ET | 4007 | 2.89 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Kodiak Sciences Inc | 167.1M | -0.7x | --- |
Outlook Therapeutics Inc | 165.5M | -0.6x | --- |
Galectin Therapeutics Inc | 169.0M | -3.5x | --- |
X4 Pharmaceuticals Inc | 169.6M | -1.4x | --- |
Atossa Therapeutics Inc | 163.5M | -5.3x | --- |
Rezolute Inc | 161.7M | -5.0x | --- |
Kodiak Sciences Inc. is a biopharmaceutical company. The Company has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) Platform, for retinal medicines. Its ABC Platform uses molecular engineering to merge the fields of protein-based and chemistry-based therapies. Its lead investigational medicine, tarcocimab, is a novel anti-vascular endothelial growth factor (anti-VEGF) antibody biopolymer conjugate under development for the treatment of high prevalence retinal vascular diseases, including diabetic retinopathy, the cause of blindness in working-age patients in the developed world, and wet age-related macular degeneration, the cause of blindness in elderly patients. Its second investigational medicine, KSI-501, is a bispecific antibody biopolymer conjugate targeting the pro-inflammatory cytokine interleukin-6 (IL-6) and VEGF. It is also developing a third investigational medicine, KSI-101, an unconjugated bispecific protein targeting IL-6 and VEGF.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $156.0M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 52.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.43 |
EPS | $-4.44 |
Book Value | $5.06 |
P/E Ratio | -0.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.